Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ELGX > SEC Filings for ELGX > Form 8-K on 16-Jul-2013All Recent SEC Filings

Show all filings for ENDOLOGIX INC /DE/



Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 12, 2013, Stefan G. Schreck, Ph.D., Chief Technology Officer and a named executive officer of Endologix, Inc. (the "Company"), notified the Company that he will be taking a three-month leave of absence from the Company starting August 1, 2013. The Company expects Dr. Schreck to return from the leave of absence in a different capacity with reduced duties and responsibilities. James E. Machek, the Company's current Vice President, Research and Development, Nellix Technologies, has been promoted to the position of Vice President, Research and Development, effective July 15, 2013, and has assumed the duties and responsibilities previously performed by Dr. Schreck.

  Add ELGX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ELGX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.